These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Phase II trial of ifosfamide in children with malignant solid tumors. Pratt CB; Horowitz ME; Meyer WH; Etcubanas E; Thompson EI; Douglass EC; Wilimas JA; Hayes FA; Green AA Cancer Treat Rep; 1987 Feb; 71(2):131-5. PubMed ID: 3100034 [TBL] [Abstract][Full Text] [Related]
4. Peripheral blood stem cell support reduces the toxicity of intensive chemotherapy for children and adolescents with metastatic sarcomas. Hawkins DS; Felgenhauer J; Park J; Kreissman S; Thomson B; Douglas J; Rowley SD; Gooley T; Sanders JE; Pendergrass TW Cancer; 2002 Sep; 95(6):1354-65. PubMed ID: 12216105 [TBL] [Abstract][Full Text] [Related]
5. Ifosfamide in the treatment of pediatric malignancies. Voûte PA; van den Berg H; Behrendt H; Michiels E; de Kraker J Semin Oncol; 1996 Jun; 23(3 Suppl 7):8-11. PubMed ID: 8711502 [TBL] [Abstract][Full Text] [Related]
6. A phase II study of cisplatin, doxorubicin, and ifosfamide with peripheral blood stem cell support in patients with skeletal osteosarcoma and variant bone tumors with a poor prognosis. Patel SR; Papadopolous N; Raymond AK; Donato M; Seong CM; Yasko AW; Lewis VO; Lin PP; Champlin R; Benjamin RS Cancer; 2004 Jul; 101(1):156-63. PubMed ID: 15222001 [TBL] [Abstract][Full Text] [Related]
7. Ifosfamide. Patient care management. Lynch MP; Ruland T Cancer Nurs; 1993 Oct; 16(5):362-5. PubMed ID: 8261384 [TBL] [Abstract][Full Text] [Related]
8. A phase II study of cisplatin, ifosfamide and epirubicin combination chemotherapy in adults with nonmetastatic and extremity osteosarcomas. Basaran M; Bavbek ES; Saglam S; Eralp L; Sakar B; Atalar AC; Bilgic B; Ozger H; Onat H Oncology; 2007; 72(3-4):255-60. PubMed ID: 18185020 [TBL] [Abstract][Full Text] [Related]
9. Ifosfamide and vinorelbine in advanced platinum-resistant ovarian cancer: excessive toxicity with a potentially active regimen. González-Martín A; Crespo C; García-López JL; Pedraza M; Garrido P; Lastra E; Moyano A Gynecol Oncol; 2002 Mar; 84(3):368-73. PubMed ID: 11855871 [TBL] [Abstract][Full Text] [Related]
10. Urinary proton magnetic resonance studies of early ifosfamide-induced nephrotoxicity and encephalopathy. Foxall PJ; Singer JM; Hartley JM; Neild GH; Lapsley M; Nicholson JK; Souhami RL Clin Cancer Res; 1997 Sep; 3(9):1507-18. PubMed ID: 9815837 [TBL] [Abstract][Full Text] [Related]
11. A Southwest Oncology Group and Cancer and Leukemia Group B phase II study of doxorubicin, dacarbazine, ifosfamide, and mesna in adults with advanced osteosarcoma, Ewing's sarcoma, and rhabdomyosarcoma. Antman K; Crowley J; Balcerzak SP; Kempf RA; Weiss RB; Clamon GH; Baker LH Cancer; 1998 Apr; 82(7):1288-95. PubMed ID: 9529020 [TBL] [Abstract][Full Text] [Related]
12. Continuously improving ifosfamide/mesna: a winning combination. Anderson P Pediatr Blood Cancer; 2010 Oct; 55(4):599-600. PubMed ID: 20589648 [No Abstract] [Full Text] [Related]
13. Ifosfamide/etoposide alternating with high-dose methotrexate: evaluation of a chemotherapy regimen for poor-risk osteosarcoma. Michelagnoli MP; Lewis IJ; Gattamaneni HR; Bailey CC; Lashford LS Br J Cancer; 1999 Mar; 79(7-8):1174-8. PubMed ID: 10098754 [TBL] [Abstract][Full Text] [Related]
14. Ongoing clinical studies of ifosfamide for pediatric cancer in the United States. Pratt CB Semin Oncol; 1996 Jun; 23(3 Suppl 6):84-90. PubMed ID: 8677456 [TBL] [Abstract][Full Text] [Related]
15. Central nervous system toxicity following the treatment of pediatric patients with ifosfamide/mesna. Pratt CB; Green AA; Horowitz ME; Meyer WH; Etcubanas E; Douglass E; Hayes FA; Thompson E; Wilimas J; Igarashi M J Clin Oncol; 1986 Aug; 4(8):1253-61. PubMed ID: 3090210 [TBL] [Abstract][Full Text] [Related]
16. [Pilot study of relapsed osteosarcoma and brain tumor with ifosfamide, carboplatin and etoposide (ICE therapy)]. Hirota T; Takeuchi M; Iwata A; Kitagawa S; Sato T; Konno K; Sawada K; Kobayashi S; Hamaguchi N; Agata H; Katano N; Fujimoto T Gan To Kagaku Ryoho; 1998 Feb; 25(3):385-90. PubMed ID: 9492832 [TBL] [Abstract][Full Text] [Related]
17. Ifosfamide- and etoposide-based chemotherapy as salvage and mobilizing regimens for poor prognosis lymphoma. Mayer J; Vásová I; Korístek Z; Navrátil M; Klabusay M; Doubek M; Vorlícek J; Cernilová I; Vodvárka P; Petráková K Eur J Haematol Suppl; 2001 Jul; 64():21-7. PubMed ID: 11486396 [TBL] [Abstract][Full Text] [Related]
18. A pilot study of cisplatin, ifosfamide and mesna in the treatment of malignant mixed mesodermal tumors of the ovary. Crotzer DR; Wolf JK; Gano JB; Gershenson DM; Levenback C Gynecol Oncol; 2007 May; 105(2):399-403. PubMed ID: 17292457 [TBL] [Abstract][Full Text] [Related]
19. [Effects of mesna (2-mercaptoethane sodium sulfonate) in children with malignant disease receiving oxazaphosphorine chemotherapy]. Iwasaku-Fujimoto M; Fujiwara F; Todo S; Morioka Y; Imashuku S Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 1):403-6. PubMed ID: 2106836 [TBL] [Abstract][Full Text] [Related]